APPB
vs
S&P 500
APPB
S&P 500
Over the past 12 months, APPB has underperformed S&P 500, delivering a return of -50% compared to the S&P 500's +16% growth.
Stocks Performance
APPB vs S&P 500
Performance Gap
APPB vs S&P 500
Performance By Year
APPB vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Applied Biosciences Corp
Glance View
Applied BioSciences Corp. is a vertically integrated company, which focuses on the development and commercialization of novel, science-driven, synthetic cannabinoid therapeutics or biopharmaceuticals that target the endocannabinoid system to treat a wide-range of diseases across multiple therapeutic area. The company is headquartered in New York City, New York. The company went IPO on 2015-11-04. The firm delivers cannabidiol (CBD) products as well as testing and analytics capabilities to its customers. The company sells consumer products, including health and wellness creams, tinctures, edibles, confections, clothing, apparel, and other various branded products. Its various brands include Remedi, Remedi Plus, HerbalPet, Champ Organics and Equine Care. Its products are focused on the medical, bioceutical and pet health industry. The firm source products from multiple production facilities in California, Colorado, Nevada and Florida. The firm's subsidiaries include Applied Products LLC, VitaCBD LLC, Trace Analytics, Inc., and SHL Management LLC, among others.
